83688 Federal Register / Vol. 89, No. 201 / Thursday, October 17, 2024 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Healthcare Infection 

Control Practices Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention announces the following 

meeting for the Healthcare Infection 

Control Practices Advisory Committee 

(HICPAC). This virtual meeting is open 

to the public. 

DATES: The meeting will be held on 

November 14, 2024, from 9 a.m. to 5 

p.m., EST, and November 15, 2024, 9 

a.m. to 12 p.m., EST. 

ADDRESSES: The meeting will be 

webcast live via the World Wide Web. 

The webcast link can be found on the 

HICPAC website. https://www.cdc.gov/ 

hicpac/meeting.html 

FOR FURTHER INFORMATION CONTACT: 

Sydnee Byrd, M.P.A., Program Analyst, 

HICPAC, Division of Healthcare Quality 

Promotion, NCEZID, CDC, 1600 Clifton 

Road NE, Mailstop H16–3, Atlanta, 

Georgia 30329–4027, Telephone: (404) 

718–8039; Email: hicpac@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Director, Division of Healthcare 

Quality Promotion (DHQP), the Director, 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

the Director, CDC; and the Secretary, 

Department of Health and Human 

Services, regarding (1) the practice of 

healthcare infection prevention and 

control; (2) strategies for surveillance, 

prevention, and control of infections, 

antimicrobial resistance, and related 

events in settings where healthcare is 

provided; and (3) periodic updating of 

CDC guidelines and other policy 

statements regarding prevention of 

healthcare-associated infections and 

healthcare-related conditions. 

Matters to be Considered: The agenda 

will include the following updates: The 

Division of Health Quality Promotion 

Updates; Isolation Precautions 

Guideline Workgroup; the NHSN 

Neonatal Pediatric Definitions Update 

and the Healthcare Personnel Guideline 

Workgroup. Agenda items are subject to 

change. 

Public Participation 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. 

Priority will be given to individuals 

who submit a request to make an oral 

public comment before the meeting 

according to the procedures below. All 

persons interested in making an oral 

public comment at the November 14–15, 

2024, HICPAC meeting must submit a 

request between October 15, 2024, and 

October 25, 2024, at https://

www.cdc.gov/hicpac/meeting.html no 

later than 5 p.m., EDT, October 25, 

2024, according to the instructions 

provided. If the number of persons 

requesting to speak is greater than can 

be reasonably accommodated during the 

scheduled time, CDC will conduct a 

lottery to determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by November 1, 2024. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–23896 Filed 10–16–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Advisory Council for the 

Elimination of Tuberculosis 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Council for the Elimination of 

Tuberculosis (ACET). This meeting is 

open to the public, limited only by the 

number of audio and web conference 

lines (1,000 lines are available). Time 

will be available for public comment 

(registration is required to provide oral 

comment; see the Oral Public Comment 

section below). 

DATES: The meeting will be held on 

December 3, 2024, from 9:30 a.m. to 

4:30 p.m., EST, and December 4, 2024, 

from 10 a.m. to 12 p.m., EST. 

Written comments must be submitted 

by November 26, 2024. Registration to 

make oral comments must also be 

submitted by November 26, 2024. 

ADDRESSES: The public meeting will be 

held virtually through Zoom. 

Registration in advance is required to 

attend. Please visit https://

cdc.zoomgov.com/webinar/register/WN_

1bRtm_1MRoiz83dFlQoHQQ to register. 

This registration for virtual attendance 

will remain open through the meeting. 

Prior to the meeting, each individual 

registrant will receive a registration 

confirmation along with an access link 

to the virtual meeting location. 

FOR FURTHER INFORMATION CONTACT: 

Marah Condit, M.S., Committee 

Management Lead, Office of Policy, 

Planning, and Partnerships, National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, Mailstop US8–6, Atlanta, 

Georgia 30329–4027. Telephone: (404) 

639–3423; Email: nchhstppolicy@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Advisory Council for 

the Elimination of Tuberculosis is 

charged with providing advice and 

recommendations regarding the 

elimination of tuberculosis (TB) to the 

Secretary of Health and Human 

Services, the Assistant Secretary for 

Health, and the Director, Centers for 

Disease Control and Prevention (CDC). 

Specifically, the Council makes 

recommendations regarding policies, 

strategies, objectives, and priorities; 

addresses the development and 

application of new technologies; 

provides guidance and review on CDC’s 

Tuberculosis Prevention Research 

portfolio and program priorities; and 

reviews the extent to which progress has 

been made toward eliminating TB. 

Matters to be Considered: The agenda 

will include discussions on: (1) CDC’s 

National Center for HIV, Viral Hepatitis, 

STD, and TB Prevention Update; (2) 

CDC’s Division of Tuberculosis 

Elimination Update; (3) TB in New 

Arrivals; (4) CDC’s National 

Tuberculosis Surveillance System and 

Molecular Surveillance; (5) 

Tuberculosis Epidemiologic Studies 

Consortium III; (6) Think. Test. Treat TB 

Campaign; (7) Laboratory Developed 

Tests Workgroup Update; and (8) Drug 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 201 / Thursday, October 17, 2024 / Notices 83689 

Shortage Workgroup Update. Agenda 

items are subject to change as priorities 

dictate. 

Public Participation 

Written Public Comment: Members of 

the public are welcome to submit 

written comments in advance of the 

meeting. Written comments must be 

submitted by emailing nchhstppolicy@

cdc.gov with subject line ‘‘ACET 

December 2024 Public Comment 

Registration’’ by November 26, 2024. 

Oral Public Comment: Individuals 

who would like to make an oral 

comment during the public comment 

period must register by emailing 

nchhstppolicy@cdc.gov with subject 

line ‘‘ACET December 2024 Public 

Comment Registration’’ by November 

26, 2024. The public comment period is 

on December 4, 2024, at 10:15 a.m., 

EST. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–23885 Filed 10–16–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Board of Scientific 

Counselors, Office of Readiness and 

Response 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting for the Board of 

Scientific Counselors, Office of 

Readiness and Response (BSC, ORR). 

This is a virtual meeting and is open to 

the public, limited only by the number 

of web conference lines available (500 

lines). Time will be available for public 

comment. 

DATES: The meeting will be held on 

November 20, 2024, from 9:30 a.m. to 

4:30 p.m., EST, and November 21, 2024, 

from 9 a.m. to 3 p.m., EST. 

ADDRESSES: Zoom virtual meeting. If 

you wish to attend the meeting, please 

register in advance by accessing the link 

at https://cdc.zoomgov.com/webinar/ 

register/WN_

sIWaL9XVRqWnBKMB2OO2wQ#/ 

registration. Instructions on accessing 

the meeting will be provided following 

registration. 

FOR FURTHER INFORMATION CONTACT: 

Dometa Ouisley, Public Health Analyst, 

Office of Science and Laboratory 

Readiness, Office of Readiness and 

Response, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H21–6, Atlanta, Georgia 

30329–4027. Telephone: (404) 639– 

7450; Email: DOuisley@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Board of Scientific 

Counselors, Office of Readiness and 

Response provides advice and guidance 

to the Secretary, Department of Health 

and Human Services (HHS); the 

Assistant Secretary for Health, HHS; the 

Director, Centers for Disease Control 

and Prevention (CDC); and the Director, 

Office of Readiness and Response 

(ORR), CDC. The Board recommends 

strategies and goals for readiness and 

response activities pertaining to 

programs and research within the 

agency and the ORR divisions and 

monitors the overall strategic direction 

and focus of the ORR divisions and 

offices. The Board may also perform 

second-level peer review of applications 

for grants-in-aid for research and 

research training activities, cooperative 

agreements, and research contract 

proposals relating to the broad areas 

within the center. For additional 

information about the Board, please 

visit https://www.cdc.gov/orr/scientificcounselors/index.html. 

Matters to be Considered: Agenda 

topics for Day 1 of the meeting include 

ORR Updates, ORR Division Director 

Updates, CDC’s Response Readiness 

Framework, and a CDCReady 

Demonstration. Agenda topics for Day 2 

include Poliovirus Containment 

Working Group Updates, ORR Science 

Agenda Working Group Updates, and 

Health Equity Working Group Updates. 

Agenda items are subject to change as 

priorities dictate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–23926 Filed 10–16–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3466–PN] 

Medicare and Medicaid Programs: 

Application From the American 

Association for Accreditation of 

Ambulatory Surgery Facilities dba 

QUAD A for Continued CMS-Approval 

of Its Outpatient Physical Therapy 

(OPT) Accreditation Program 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice with request for 

comment. 

SUMMARY: This notice acknowledges the 

receipt of an application from the 

American Association for Accreditation 

of Ambulatory Surgery Facilities, dba 

QUAD A, for continued recognition as 

a national accrediting organization for 

outpatient physical therapy providers 

that wish to participate in the Medicare 

or Medicaid programs. 

DATES: To be assured consideration, 

comments must be received at one of 

the addresses provided below, no later 

than 5 p.m. on November 18, 2024. 

ADDRESSES: In commenting, refer to file 

code CMS–3466–PN. Because of staff 

and resource limitations, we cannot 

accept comments by facsimile (FAX) 

transmission. 

Comments, including mass comment 

submissions, must be submitted in one 

of the following three ways (please 

choose only one of the ways listed): 

1. Electronically. You may submit 

electronic comments on this regulation 

to https://www.regulations.gov. Follow 

the ‘‘Submit a comment’’ instructions. 

2. By regular mail. You may mail 

written comments to the following 

address ONLY: Centers for Medicare & 

Medicaid Services, Department of 

Health and Human Services, Attention: 

CMS–3466–PN, P.O. Box 8010, 

Baltimore, MD 21244–8010. 


ddrumheller on DSK120RN23PROD with NOTICES1